Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 206   

Articles published

VRX 8.81 +0.20 (2.32%)
price chart
What Canopy Growth Corp can Learn From Valeant Pharmaceuticals Intl Inc
In case you have yet to hear the news, please brace yourself. Shares of Valeant Pharmaceuticals Intl Inc (TSX:VRX)(NYSE:VRX) hit a new 52-week low this past Friday.
Valeant Pharmaceuticals Nearing Capitulation, Breaks $8.50  Seeking Alpha
Valeant Pharmaceuticals International, Inc. (VRX) has current market ...  StandardOracle
Valeant Pharmaceuticals International Inc. tumbles to $9.52 today for first ...
Valeant dropped as much as 6.4 per cent to US$9.52 on Wednesday, its lowest intraday level since 2009, after the Australian Business Review reported that the company was struggling to sell a pharmaceutical distribution unit for as much as it sought.
Valeant trades in below $10 for first time since 2008  CNBC
What Can Valeant Pharmaceuticals Intl Inc (VRX) Do to Get out of This Mess?  Smarter Analyst
Valeant Pharmaceuticals Intl Inc.: Is a Recovery Possible?
In a little over one year, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has gone from being a core holding to virtually nothing.
Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ ...
LAVAL, Quebec, April 21, 2017 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that following the evaluation and approval of its Patient Access and Pricing Committee (PAPC), the company has decided to list ...
Valeant prices psoriasis treatment at $3500 per month  The Globe and Mail
Could Valeant Pharmaceuticals Intl Inc. Go to $0?
Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX) has been a huge destroyer of wealth for investors who were too high on the hype.
With Ackman Gone, Has Valeant Pharmaceuticals Intl Inc. Hit Rock Bottom?
I'll be looking specifically at Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and the path the company has taken since iconic activist investor Bill Ackman announced that he dumped his stake in the Canadian pharmaceutical giant, reportedly ...
What Makes Valeant Pharmaceuticals (VRX) a Strong Sell?  Yahoo Finance
Former CEO Pearson sues Valeant over withheld shares  The Globe and Mail
How Much Longer Should You Hold Shares of Valeant Pharmaceuticals Intl Inc.?
Over the past few weeks, shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have been in the news … again. The most recent reason Valeant was in the news was because well-known hedge fund manager Bill Ackman announced that he and ...
Valeant Pharmaceuticals Intl Inc (VRX) Legal Mess Is An Existential Threat
As if declining EBITDA, political pressure, and debt were not bad enough, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) must contend with the risk of adverse litigation from opponents as varied as the government, investors, and even its former CEO, Mike ...
Here Why You Shouldn't Give Up on Valeant Pharmaceuticals Intl Inc (VRX) Just Yet
It is not much of a surprise that troubled pharma company Valeant Pharmaceuticals Intl Inc (VRX) has not had an easy time of late.
Valeant: The Math Doesn't Add Up
During the 2nd quarter of 2016, Valeant (NYSE:VRX) said that they would sell non-core assets to reduce their debt by more than $5 billion within 18 months.